CD8+ Tsen populations were also not increased (30.7%) in another 72-year-old patient with breast cancer with bone metastases who had no previous treatment with cytotoxic agents and is currently treated with abemaciclib (Fig. 3b). The gene discussed is CD8A; the disease is breast cancer.